Naslovnica / Cover

Sadržaj / Table of Contents

Danijel Planinc.
Klasifikacija i klinički značaj kardiomiopatija.
Classification and clinical importance of cardiomyopathies.

Perry M. Elliott, Saidi A. Mohiddin.
Almanah 2011.: kardiomiopatije. Časopisi nacionalnih društava predstavljaju odabrana istraživanja koja predstavljaju napredak u kliničkoj kardiologiji.
Almanac 2011: Cardiomyopathiaes. The national society journals present selected research that has driven recent advances in clinical cardiology.

Duška Glavaš.
Rezultati istraživanja SHIFT i mjesto ivabradina u liječenju bolesnika s kroničnim zatajivanjem srca u sinusnom ritmu.
The SHIFT trial results and position of ivabradine in the treatment of patients with chronic heart failure in sinus rhythm.

Saša Magaš.
Dijabetes i koronarna bolest srca: važnost regulacije glikemije.
Diabetes and coronary artery disease: the importance of glycemic control.

Hrvoje Pintarić, Zdravko Babić, Ivan Zeljković, Ivica Benko.
Registar perkutanih koronarnih intervencija u Kliničkom bolničkom centru Sestre milosrdnice
Percutaneous Coronary Intervention Registry in University Hospital Centre Sestre milosrdnice.

Nikola Bulj, Vjeran Nikolić-Heitzler.
Antiagregacijska terapija i stomatološki postupci u primarnoj zdravstvenoj zaštiti.
Antiaggregation therapy and dental procedures in primary healthcare.

Darko Počanić.
Zapisnik sa sjednice Upravnog odbora Hrvatskog kardiološkog društva 12. prosinca 2011.
Minutes of the meeting of the Management Board of the Croatian Cardiac Society of 12th Dec 2011.

Jure Samardžić.
2nd Dubrovnik Cardiology Highlights – an ESC Update Programme in Cardiology
Hrvatska, Dubrovnik, Hotel Excelsior, 29. 9. - 2. 10. 2011.
2nd Dubrovnik Cardiology Highlights – an ESC Update Programme in Cardiology
Croatia, Dubrovnik, Hotel Excelsior, 29 Sept - 2 Oct 2011

Mario Pehar.
Prednosti perindoprila kao monoterapije i kombinacije s indapamidom u odnosu na ostale ACE inhibitore u kardiovaskularnih bolesnika.
Advantages of perindopril as monotherapy and combinations with indapamide compared to other ACE inhibitors in cardiovascular patients.